Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 811-213-0 | CAS number: 66711-86-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Two-generation study with Rat exposure via the inhalation route, performed according to OECD Guideline 416 and the EPA Guideline OPPTS 870.3800 and following GLP principles, the parental NOAEL for HFO-1336mzz-E was found to be at least 7500 ppm based on clinical signs observed at the highest dose tested (12500 ppm), whereas the NOAEL for reproduction was found to be at least 12500 ppm. Reliability - K1;
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 83 750 mg/m³
- Study duration:
- chronic
- Species:
- rat
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
A Prenatal development toxicity study performed according to OECD 414 on female rats, exposed via whole body inhalation, was assessed as K1 study and used as supportive study.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEC
- 50 322 mg/m³
- Study duration:
- subchronic
- Species:
- rat
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Reproductive toxicity includes adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring.
A GLP two-generation reproduction study was conducted in Crl:WI(Han) rats (30/sex/concentration) at exposure levels of 0, 5000, 7500, or 12500 ppm (0, 33500, 50250, or 83750 mg/m3) of the substance in air according to OECD test guideline 416. Exposures were via whole-body inhalation for 6 hours per day, 7 days per week for at least 70 consecutive days prior to mating and continuing through the day prior to euthanasia. Exposure was suspended from Gestation Day 21 through Lactation Day 4 for gravid and presumed gravid females. Exposure for the offspring selected to constitute the P1 parental generation began on the day of weaning, PND 28.
In the 12500 ppm group, 1 male was euthanized in extremis and 1 male was found dead in the F0 generation. Test substance-related clinical findings included tremors for F0 and F1 males and females in the 12500 ppm group and clonic convulsions for F0 females in the 12500 ppm group at the midpoint of exposure; these findings were considered adverse. No adverse test substance-related effects were noted on F0 or F1 parental body weights, body weight gains, food consumption, or food efficiency at any exposure concentration. No test substance-related effects were noted on F0 or F1 reproductive performance (mating, fertility, copulation, or conception), estrous cyclicity, gestation lengths, the process of parturition, precoital intervals, or spermatogenesis at any exposure concentration. There were no test substance-related effects on attainment of balanopreputial separation and vaginal patency or body weights at attainment of these developmental landmarks in the F1 pups at any exposure level. There were no test substance-related effects noted on F1 and F2 mean numbers of pups born, live litter size on PND 0, percentage of males, or postnatal survival. Mean F1 and F2 male and female pup body weights and body weight changes in the 5000, 7500, and 12500 ppm groups were unaffected by test substance exposure throughout the postnatal period. There were no test substance-related macroscopic findings noted at any dosage level in the F1 and F2 pups that were found dead or pups that were euthanized at the scheduled necropsy on PND 28. No test substance-related effects on organ weights were observed for F1 and F2 pups on PND 28. No test substance-related adverse macroscopic or microscopic findings or organ weight alterations were noted for F0 and F1 males or females at any exposure level. Based on the effects on survival for F0 males at 12500 ppm and adverse clinical findings of tremors noted for F0 and F1 males and females at 12500 ppm at the midpoint of exposure, an exposure level of 7500 ppm (50250 mg/m3) was considered to be the NOAEC for systemic toxicity. Due to the lack of effects on reproductive parameters or survival and growth of the offspring during the pre-weaning period, the NOAEC for parental reproductive toxicity and neonatal toxicity was 12500 ppm (83750 mg/m3), the highest exposure concentration evaluated.
A GLP prenatal developmental toxicity study was conducted according to OECD test guideline 414 wherein five groups of 24 time-mated nulliparous female Wistar rats were exposed to 0, 1000, 5000, 7500 or 15000 ppm (0, 6700, 33500, 50250, or 100500 mg/m3) of the substance via whole-body inhalation for 6 hours per day beginning on gestation day (GD) 6 up to and including GD 19. No maternal, embryo, or fetal lethality or fetal structural malformations were observed at any exposure concentration. A lower maternal body weight gain during gestation was observed and a reduced food intake after the start of exposure from GD 6-12 was noted in the 15000ppm exposure group. Mean fetus weight and mean placenta weight were decreased in the 15000 ppm exposure group for both male and female fetuses. Skeletal examination showed reduced ossification in the fetuses in the 15000 ppm exposure group, which was indicative of growth retardation and considered to be related to the lower fetus weight in this group. Under the conditions of this study, the NOAEC for maternal and fetal effects was 7500 ppm (50250 mg/m3).
In conclusion, no test substance-related adverse effects on reproductive outcomes or unique pre- or postnatal developmental toxicity were observed after exposure to the test substance. These assessments were made in GLP guideline studies carried out in rats. The substance does not need to be classified for reproductive or developmental toxicity according the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.